Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Illinois Pain Institute Avoids Global Cyberattacks by Focusing on Patient Care and Adult Stem Cell Treatments
  • USA - English


News provided by

Illinois Pain

May 18, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX

John V. Prunskis (left) and Terri Dallas-Prunskis (right); husband -and-wife cofounders of the Illinois Pain Institute and The Regenerative Stem Cell Institute
John V. Prunskis (left) and Terri Dallas-Prunskis (right); husband -and-wife cofounders of the Illinois Pain Institute and The Regenerative Stem Cell Institute

The outcome data for spine and musculoskeletal pain is showing that 76-81% of patients are having positive results from the deployment of adult autologous stem cells using the proven technique we employ.

Post this

Chicago, Illinois (PRWEB) May 18, 2017 -- On May 12, 2017, many of the large hospitals sent affiliated doctors and staff emails alerting them of potential system hacks and the loss of patient electronic health records (EHR) due to the computer virus dubbed “WannaCry” that swept the world. The virus would go on to affect hundreds of thousands of computers in over a hundred countries. When John V. Prunskis, MD (Medical Director of The Illinois Pain Institute and The Regenerative Stem Cell Institute) was alerted of these panicked notices and the spread of the attack, he was unfazed because he knew his patients’ medical records would remain secure because his team chose not to implement an EHR program.

After the passage of the Health Information Technology for Economic and Clinical Health (HITECH) Act in 2009 and the Affordable Care Act (ACA) in 2010, many of the nation’s health care providers clambered to hastily switch to an eligible EHR systems to take advantage of government-sponsored incentives typically ranging in the millions of dollars. Meanwhile, Dr. Prunskis and his team at the Illinois Pain Institute opted to focus their attention on pursuing further technological advancements in life-changing techniques including the state of the art of autologous stem cell treatments.

“When the government subsidy programs were rolled out, there was a grab by hospitals and medical practices to satisfy the minimum usage requirements to qualify for the cash credits. We explored the EHR options that were out there and were unimpressed. They were only going to decrease our ability to deliver attentive and efficient care to our patients and were not meeting our operational and security needs. These were sacrifices we were not willing to make,” said Dr. Prunskis.

While many of their peers wrestled with the implementation of the clunky software, Dr. Prunskis and his team continued to actively engage the medical community, exchanging best practices on the latest techniques for the diagnosis and treatment of painful and degenerative conditions. They researched and implemented a breakthrough procedure using adult autologous stem cells with significant results in the treatment of orthopedic, musculoskeletal, spine, cardiopulmonary, urologic, neurologic (including stroke and concussion), gastrointestinal, autoimmune, and other diseases.  

After seeing the compelling outcome data and meeting with successfully treated patients, Dr. Prunskis and his wife, Terri Dallas-Prunskis, MD decided to establish The Regenerative Stem Cell Institute to focus on advancing access and quality care in adult stem cell regenerative medicine to help people suffering from inflammatory, degenerative, and other conditions.

Dr. Terri Dallas-Prunskis states, “The outcome data for spine and musculoskeletal pain is showing that 76-81% of patients are having positive results from the deployment of adult autologous stem cells using the proven technique we employ.”

The procedure uses autologous adult adipose-derived stems cells - which means they come directly from the patient's own fat stores. The stem cells are then cleaned and prepared for deployment at both the affected sites and into the bloodstream through an IV. Stem cells are unspecified cells which are capable of differentiation depending on the body’s needs. By introducing the highly-concentrated cells, the body becomes equipped to heal itself. The procedure has been most commonly used for orthopedic and spinal conditions; however, patients have reported significant improvement from concussions, stroke, and even ALS.

The husband and wife duo have a long track record of employing non-surgical treatments that address the root cause of the pain rather than masking it through opioid narcotics or other medications. In 1992, Dr. Terri Dallas-Prunskis left her position as a chairwoman of the interventional pain program at the University of Chicago Medical School to join Dr. John V. Prunskis in founding the Illinois Pain Institute, focusing on the precise diagnosis and treatment of painful conditions.

The pair has lectured extensively to both US and international audiences and, together, hold the highest accreditations in their specialty. Notably, Dr. Prunskis has been chosen by his peers as top Chicago pain management doctor in his specialty an impressive eight times.

Despite achieving medical excellence for a combined six decades, the husband and wife team continues to relentlessly pursue more effective ways to help their patients live their best lives. The founding of The Regenerative Stem Cell Institute is the natural progression of years of disciplined patient care. “We believe in living life to your fullest potential. For us at The Regenerative Stem Cell Institute, that means making sure our patients are able to do the things they like with the people they love, without the limitations of painful conditions and avoiding surgery,” said Dr. Prunskis. 

About Illinois Pain Institute

Started in 1992, IPI is the longest established multi-site Interventional Pain Practice in the Chicago area. The Chicago pain management practice has grown to include seven locations in the Chicago suburbs: Elgin, Barrington, McHenry, Itasca, Libertyville, Huntley and Elmhurst; located in Lake, DuPage, Kane and McHenry counties.

IPI has been an eight-time winner of the Castle Connolly “Top Doctor” award. The practice is completely focused on diagnosing, identifying and fixing the problem and not masking it. IPI physicians provide precise diagnosis and treatment of back pain, neck pain, sciatica, headaches and other painful conditions. The physicians at IPI have expertise in diagnosing and relieving these problems and many other painful conditions by addressing and fixing the source of the pain in a compassionate manner. Visit http://illinoispain.com for more information and scheduling or simply call (888) 925-0984.

David, Illinois Pain, http://illinoispain.com, +1 (877) 791-6466, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.